Chen Song

Title: Innovations by Inventor Chen Song

Introduction

Chen Song is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid manipulation. His innovative work has led to the development of a unique patent that enhances the study of genetic mutations.

Latest Patents

Chen Song holds a patent titled "Selective degradation of wild-type DNA and enrichment of mutant alleles using nuclease." This patent provides methods for preparing a target mutant nucleic acid for subsequent enrichment relative to a wild-type nucleic acid. The methods utilize nucleases that exhibit substantially higher activity on double-stranded DNA compared to single-stranded DNA or RNA. Additionally, the patent includes techniques for enriching target mutant nucleic acids and preparing unmethylated/methylated nucleic acids of interest for further enrichment.

Career Highlights

Chen Song is affiliated with the Dana-Farber Cancer Institute Inc., where he applies his expertise in genetic research. His work at this prestigious institution has allowed him to contribute to advancements in cancer research and treatment methodologies.

Collaborations

Chen collaborates with Gerassimos M Makrigiorgos, a fellow researcher at the Dana-Farber Cancer Institute. Their partnership focuses on enhancing the understanding of genetic variations and their implications in cancer.

Conclusion

Chen Song's innovative contributions to the field of molecular biology, particularly through his patent on nucleic acid manipulation, highlight his role as a leading inventor in genetic research. His work continues to pave the way for advancements in understanding genetic mutations and their applications in medicine.